Mangalam Drugs & OrganicsNSE:MANGALAM -0.96%43 Quick Ratio is 0.27 as of Mar. 2026, which is 41% below its 10-year median of 0.46. GuruFocus rates NSE:MANGALAM with a GF Score™ of 43/100 and a GF Value™ of ₹64.85 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 994 Drug Manufacturers companies, Mangalam Drugs & Organics ranks worse than 94.16% on this metric.
Mangalam Drugs & Organics has a quick ratio of 0.27. It indicates that the company cannot currently fully pay back its current liabilities.
The historical rank and industry rank for Mangalam Drugs & Organics's Quick Ratio or its related term are showing as below:
NSE:MANGALAM'
s Quick Ratio Range Over the Past 10 Years
Min: 0.27 Med: 0.46 Max: 0.75
Current: 0.27
During the past 13 years, Mangalam Drugs & Organics's highest Quick Ratio was 0.75. The lowest was 0.27. And the median was 0.46.
NSE:MANGALAM's Quick Ratio is ranked worse than 94.16% of 994
companies
in the Drug Manufacturers industry
Industry Median: 1.45
vs NSE:MANGALAM: 0.27
Mangalam Drugs & Organics (NSE:MANGALAM) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Mangalam Drugs & Organics Quick Ratio Related Terms
Mangalam Drugs & Organics Quick Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Mangalam Drugs & Organics's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mangalam Drugs & Organics Quick Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Mangalam Drugs & Organics's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Mangalam Drugs & Organics's Quick Ratio falls into.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
Mangalam Drugs & Organics's Quick Ratio for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mangalam Drugs & Organics (NSE:MANGALAM) has a Quick Ratio of 0.27 as of Mar. 2026. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Mangalam Drugs & Organics and its competitors. This is 41% below median its historical median of 0.46. Over the past decade, Mangalam Drugs & Organics' Quick Ratio has ranged from 0.27 to 0.75. According to the industry distribution chart, Mangalam Drugs & Organics ranks #936 out of 994 companies in the Drug Manufacturers industry, placing it in the top 94.2%.
Is Mangalam Drugs & Organics' Quick Ratio too high?
Mangalam Drugs & Organics' current Quick Ratio of 0.27 is 41% below median its 10-year median of 0.46. Over the past 10 years, this metric has ranged from a low of 0.27 to a high of 0.75. The Drug Manufacturers industry median Quick Ratio is 1.45. Mangalam Drugs & Organics' value of 0.27 is 81.4% below this industry median. Based on the distribution chart, Mangalam Drugs & Organics ranks #936 out of 994 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Mangalam Drugs & Organics has a GF Score™ of 43/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Mangalam Drugs & Organics' Quick Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Mangalam Drugs & Organics ranks #936 out of 994 companies for Quick Ratio. This places Mangalam Drugs & Organics in the lower half of its industry. The industry median Quick Ratio is 1.45. Mangalam Drugs & Organics' value of 0.27 is 81.4% below this benchmark. Historically, Mangalam Drugs & Organics' own Quick Ratio has ranged from 0.27 to 0.75 over the past decade. While the company's 10-year median is 0.46 vs. the industry median of 1.45, Mangalam Drugs & Organics has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Drug Manufacturers company?
The median Quick Ratio among Drug Manufacturers companies is 1.45, based on 994 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Mangalam Drugs & Organics's current Quick Ratio of 0.27 is 81.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Mangalam Drugs & Organics and its competitors. For the Drug Manufacturers industry, the median Quick Ratio is 1.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mangalam Drugs & Organics's current Quick Ratio is 0.27, which is 41% below median its own 10-year median of 0.46. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mangalam Drugs & Organics stock overvalued right now?
Based on GuruFocus' analysis, Mangalam Drugs & Organics (NSE:MANGALAM) is currently considered Possible Value Trap. The stock's GF Value™ is ₹64.85, compared to a current price of ₹28.79 — trading 55.6% below its estimated fair value. The current Quick Ratio is 0.27, which is 41% below median its 10-year median of 0.46 and 81.4% below the Drug Manufacturers industry median of 1.45. Mangalam Drugs & Organics' overall GF Score™ is 43/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Mangalam Drugs & Organics (NSE:MANGALAM), the current Quick Ratio is 0.27 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Mangalam Drugs & Organics (NSE:MANGALAM) Overvalued in 2026?
Based on GuruFocus' analysis, Mangalam Drugs & Organics stock appears to be undervalued.
The current stock price of ₹28.79 is trading 55.6% below its estimated GF Value™ of ₹64.85.
GuruFocus considers Mangalam Drugs & Organics to be Possible Value Trap.
Key valuation signals for NSE:MANGALAM:
Quick Ratio: 0.27 (41% below median its 10-year median of 0.46)
GF Value™: ₹64.85 vs. price of ₹28.79 (55.6% below fair value)
Industry Position: 81.4% below the Drug Manufacturers median (#936 of 994)
No single metric tells the full story. See the NSE:MANGALAM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Mangalam Drugs & Organics Ltd commenced its manufacturing of Active Pharmaceutical Ingredients (APIs) and intermediates. The company is engaged in the manufacture and sale of APIs for various therapeutic segments, including anti-malaria, anti-retroviral, and anti-hypertensive. It is approved by the Bill Clinton Foundation. The company is actively producing Pyronaridine Tetraphosphate, a new API used in antimalarial treatments. The company has received prequalification from the World Health Organization (WHO) for both micronized and non-micronized forms of Pyronaridine Phosphate.
43GF Score
Get the complete analysis for NSE:MANGALAM
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:MANGALAM has been successfully added to your 
